https://www.prweb.com/releases/sonivie-receives-fda-breakthrough-device-designation-for-the-tivus-system-in-the-treatment-of-pulmonary-arterial-hypertension-pah--818390629.html
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System in the Treatment of...
/PRNewswire-PRWeb/ -- SoniVie, an Israeli company developing a novel system for the treatment of PAH, today announced that it has been granted Breakthrough...